Inflammation & Prostate Cancer
/Men who show signs of chronic inflammation in non-cancerous prostate tissue may have nearly twice the risk of actually having prostate cancer than those with no inflammation.
Read MoreMen who show signs of chronic inflammation in non-cancerous prostate tissue may have nearly twice the risk of actually having prostate cancer than those with no inflammation.
Read MoreProstate cancer researchers studying genetic variations have pinpointed 45 genes associated with disease development and progression.
Read MoreA new study provides a major link between low levels of vitamin D and aggressive prostate cancer.
Read MoreAccording to a recent study in the journal of BMC Urology, a higher percentage of men participating in high levels of physical activity 5-7 times per week preoperatively had a reduced need for sick leave after radical prostatectomy.
Read MoreA mathematical model that uses four consecutive prostate-specific antigen (PSA) test results from a patient who had prostate cancer surgery can predict the time it might take for the disease to relapse.
Read MoreIf your man is diagnosed with prostate cancer, his 15-year relative survival rate is 95 percent – and it can be even higher if you are standing by him for the battle.
Read MoreAside from non-melanoma skin cancer, prostate cancer is the most common cancer among men in the U.S., according to the Centers for Disease Control and Prevention. It is also one of the leading causes of cancer death among men of all races.
Read MoreMen with very high-risk prostate cancer, who are treated at hospitals with a high proportion of administered radical local treatment (radiotherapy or prostatectomy), only have half of the mortality risk of men who are treated at hospitals with the lowest proportion.
Read MoreCancer researchers have developed a computational approach for analyzing patient-specific data to help doctors choose the most effective drugs for individual patients.
Read MoreOver 90 percent of prostate cancers are detected at a curable stage, with men more likely to die of other diseases than from this cancer.
Read MoreThe Gleason score is a system using to grade prostate cancer tissue which is dependent upon how it looks when analyzed under a microscope. The Gleason score ranges from two to ten and is an indicator of how likely it is that the cancer will spread. It also provides the doctor with the necessary information needed to select the most optimal treatment plan for the patient. Similar to staging prostate cancer, grade are given to each prostate cancer case to determine the severity of the disease. A urologist will assign a grade to the prostate cancer after the patient has undergone a prostate biopsy. The tissue samples are sent to a laboratory to be analyzed by a pathologist.
Read More